NANTBIO

Cell-derived preparations for clinical, medicinal, therapeutic, and medical diagnostic purposes; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for immunotherapy treatment; Pharmaceutical preparations derived from monoclonal antibodies for the treatment of cancer; Pharmaceutical preparations, namely, epitope mapping systems, composed of antibodies, for use in the diagnosis and treatment of cancer; Pharmaceutical preparations for the treatment of allograft rejection; Therapeutic antibodies and immune system modulators, namely, pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations, namely, small molecule therapies for treating cancer; Vaccines